DocuSign (DOCU) Shares Pop on Restructuring Plan, 9% Staff Cuts
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2024
- Wall St set for flat open as Middle East jitters ease, Netflix slumps
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Stocks off two-month low as fear of Middle East escalation eases
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Netflix (NFLX) Tops Q1 EPS by 77c, Offers Guidance
- Netflix, Tesla, Amex, P&G fall premarket; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
DocuSign Inc. (DOCU) Restructuring Timing 'Interesting' According to Analyst
September 29, 2022 12:52 PM EDTWolfe Research cut its price target on shares of DocuSign Inc. (NASDAQ: DOCU) to $44 from $53, reiterating an Underperform rating on Thursday, in reaction to the news that the company authorized a restructuring plan that will reduce the current workforce by approximately 9%.
Analyst Alex Zukin told investors in a research article that the company estimates it will incur charges of approximately $30-$40M in connection with... More
IBM (IBM) Not Immune to Macro Headwinds- UBS
September 28, 2022 2:05 PM EDTUBS cut IBM's price target to $112 from $118 on Wednesday, maintaining a Sell rating on the stock, stating the company is not immune to macro.
Analyst David Vogt also lowered estimates as they believe consulting revenue growth is likely to slow faster than expected, IBM is facing incremental FX headwinds, and margins... More
